Search

"prevention" - search results

If you're not happy with the results, please do another search

Opioid Abuse and Misuse: Pharmacy’s Role in Prevention, Monitoring and Management

Rebecca Chater, RPh, MPH, FAPhA, Director of Healthcare Strategy, Omnicell. In light of the scope of opioid abuse and misuse, this session explores the societal impact of opioid misuse, as well as system and patient-level solutions to improve management of opioids throughout the healthcare continuum. Rebecca reviews implementation of opioid-related quality measures and other initiatives to mitigate the crisis,...

ED Pilot Project to Address Opioid Abuse and Suicide Prevention at Bon Secours Mercy Health

Aliya Jones, MD, Chair, Department of Behavioral Health, Bon Secours Baltimore Health System, Allan Austin, Senior Organizational Effectiveness Consultant and Allen Tien, MD, MHS, President and Chief Science Officer, mdlogix.  The ED Diversion program was designed to provide comprehensive screening and improved referral processes for high utilizers of the Bon Secours Emergency Department, enabling better care and outcomes for...

Patient Opioid Abuse Detection and Prevention: New Discovery Analytic Approaches

Derek Pederson, MA, MBA, Vice President Medical Informatics, and Peter N. Toensing, MD, Medical Director for Episode Analytics, Optum.  The increasing power of data and analytics capabilities to help providers identify, address and prevent opioid abuse can be augmented by combining pharmacy utilization and benefit claims data to create a holistic view of opioid abuse patterns and risks. Derek...

Pop Health: Leveraging Technology to Drive Prevention at Mercy Health

Erin Fries, MD, Chief Clinical Officer, Mercy Health, Tarah Knaresboro, VUI Design Manager, and Samuel Moore, Client Services Manager, Emmi.  Managing a population's health means more than helping people when they're ill - it means driving behaviors that will keep them healthy. But the resources required to do this effectively are often costly and in short supply. Without consistent...

CDS Malfunctions: Causes, Detection and Prevention

Adam Wright, PhD, Associate Professor of Medicine, Harvard Medical School, Senior Scientist, Brigham and Women's Hospital. Clinical decision support (CDS) systems, when effectively designed and used, are powerful tools for improving the quality and safety of healthcare but can be complex to develop and maintain. Dr. Wright presents research, funded by the National Library of Medicine, on CDS malfunctions...

Surveillance: Optimizing Performance to Meet Infection Prevention and ADE Compliance

Tina Moen, PharmD, Chief Clinical Officer, Clinicians, Thomson Reuters Healthcare. Surveillance and reporting of clinical data for Infection prevention (IP) and Adverse Drug Event (ADE) intervention can represent a significant and ongoing resource drain on clinical and IT staff. And, with Stage 2 Meaningful Use criteria recommending that evidence-based Clinical Decision Support (CDS) be available to point-of-care clinicians once...

FTC Red Flag Rule Implementation and ID Theft Prevention

Paul Doegler, Managing Director Compliance, and Michael Sawyer, Privacy Officer, Pershing LLC, and Evelyn Briggs, IM Director Security and Compliance, CHRISTUS Health. Hackers today are much like pirates: looking for easy targets that quickly produce the most financial gain. Despite the promotion about simple identity theft countermeasures, this remains one of the top threats for individual users and organizations....

Ambulatory ADE’s: Research Data and Opportunities for Prevention

Dr. Tejal K. Gandhi, M.D. M.P.H., Director of Patient Safety-Brigham and Women’s Hospital, Partners HealthCare System, Inc., Boston MA, reviews her NEJM published research study. She will describe the study data on 661 patients demonstrating the occurrence of ADE’s, and the severity, preventability, and causes. Dr. Gandhi will also discuss other significant ambulatory patient safety issues such as medication...

WEBINAR | COVID-19: What Do We Really Know about Emergence, Treatments and Vaccines?

John McConnell, Editor in Chief, The Lancet Infectious Diseases.  Despite an unprecedented scientific effort, uncertainties remain in our knowledge of COVID-19. Efforts to prevent and treat the COVID-19 pandemic have been further complicated by the spread of misinformation about the disease. This teleconference attempts to untangle myth from reality in what we know about the origins of COVID-19, its...

Matthew Sims, MD, PhD, FACP, FIDSA

Dr. Sims received his MD and PhD from Stony Brook University with his PhD in Genetics focused on antifungal resistance. He went on to an Internal Medicine residency at Stony Brook and from there to University of Rochester for his Infectious Diseases fellowship followed by an Infectious Diseases research fellowship focused on the impact of antiretroviral resistance mutations on...